Refreshing results…
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer
Download from aacrjournals.orgPersistent mutation burden drives sustained anti-tumor immune responses
Download from www.nature.comTumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
Download from rupress.orgTranscriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Download from www.nature.comMismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Download from www.ncbi.nlm.nih.govMissing publications? Search for publications with a matching author name.